ReviewJournal of clinical medicine2026

Reassessing the Role of Anthracyclines in Early HER2-Positive Breast Cancer in the Era of HER2-Targeted Therapy and Treatment De-Escalation: A Systematic Review and Narrative Synthesis.

Zhuldyz Myrzabay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.